Sabra Healthcare Reit Stock Performance

SBRA Stock  USD 19.93  0.09  0.45%   
Sabra Healthcare has a performance score of 8 on a scale of 0 to 100. The entity has a beta of -0.31, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sabra Healthcare are expected to decrease at a much lower rate. During the bear market, Sabra Healthcare is likely to outperform the market. Sabra Healthcare REIT right now has a risk of 1.31%. Please validate Sabra Healthcare maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if Sabra Healthcare will be following its existing price patterns.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Healthcare REIT are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sabra Healthcare may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
 
Sabra Healthcare dividend paid on 28th of November 2025
11/28/2025
Begin Period Cash Flow66.3 M
Total Cashflows From Investing Activities-378 M

Sabra Healthcare Relative Risk vs. Return Landscape

If you would invest  1,834  in Sabra Healthcare REIT on November 22, 2025 and sell it today you would earn a total of  158.50  from holding Sabra Healthcare REIT or generate 8.64% return on investment over 90 days. Sabra Healthcare REIT is currently generating 0.1467% in daily expected returns and assumes 1.3125% risk (volatility on return distribution) over the 90 days horizon. In different words, 11% of stocks are less volatile than Sabra, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Sabra Healthcare is expected to generate 1.76 times more return on investment than the market. However, the company is 1.76 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of risk.

Sabra Healthcare Target Price Odds to finish over Current Price

The tendency of Sabra Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 19.93 90 days 19.93 
roughly 2.38
Based on a normal probability distribution, the odds of Sabra Healthcare to move above the current price in 90 days from now is roughly 2.38 (This Sabra Healthcare REIT probability density function shows the probability of Sabra Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Sabra Healthcare REIT has a beta of -0.31. This usually implies as returns on the benchmark increase, returns on holding Sabra Healthcare are expected to decrease at a much lower rate. During a bear market, however, Sabra Healthcare REIT is likely to outperform the market. Additionally Sabra Healthcare REIT has an alpha of 0.1583, implying that it can generate a 0.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Sabra Healthcare Price Density   
       Price  

Predictive Modules for Sabra Healthcare

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sabra Healthcare REIT. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
18.5319.8521.17
Details
Intrinsic
Valuation
LowRealHigh
18.0119.3320.65
Details
Naive
Forecast
LowNextHigh
20.0621.3822.71
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7.2419.6432.05
Details

Sabra Healthcare Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sabra Healthcare is not an exception. The market had few large corrections towards the Sabra Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sabra Healthcare REIT, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sabra Healthcare within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.16
β
Beta against Dow Jones-0.31
σ
Overall volatility
0.53
Ir
Information ratio 0.05

Sabra Healthcare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sabra Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sabra Healthcare REIT can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sabra Healthcare REIT currently holds 1.26 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity.
Over 99.0% of Sabra Healthcare shares are owned by institutional investors

Sabra Healthcare Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sabra Stock often depends not only on the future outlook of the current and potential Sabra Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sabra Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding244.5 M
Cash And Short Term Investments71.5 M

Sabra Healthcare Fundamentals Growth

Sabra Stock prices reflect investors' perceptions of the future prospects and financial health of Sabra Healthcare, and Sabra Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sabra Stock performance.

About Sabra Healthcare Performance

By analyzing Sabra Healthcare's fundamental ratios, stakeholders can gain valuable insights into Sabra Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sabra Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sabra Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
As of March 31, 2022, Sabras investment portfolio included 416 real estate properties held for investment. As of March 31, 2022, Sabras real estate properties held for investment included 41,445 bedsunits, spread across the United States and Canada. Sabra REIT operates under REITHealthcare Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 42 people.

Things to note about Sabra Healthcare REIT performance evaluation

Checking the ongoing alerts about Sabra Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sabra Healthcare REIT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sabra Healthcare REIT currently holds 1.26 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity.
Over 99.0% of Sabra Healthcare shares are owned by institutional investors
Evaluating Sabra Healthcare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Sabra Healthcare's stock performance include:
  • Analyzing Sabra Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sabra Healthcare's stock is overvalued or undervalued compared to its peers.
  • Examining Sabra Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Sabra Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sabra Healthcare's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Sabra Healthcare's stock. These opinions can provide insight into Sabra Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Sabra Healthcare's stock performance is not an exact science, and many factors can impact Sabra Healthcare's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Sabra Stock analysis

When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes